Natural Killer-like Nonspecific Tumor Cell Lysis Mediated by Specific Ligand-activated Valpha14 NKT Cells

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1998 May 20

PMID 9576945

Citations 166

Authors

T Kawano

J Cui

Y Koezuka

I Toura

Y Kaneko

H Sato

E Kondo

M Harada

H Koseki

T Nakayama

Y Tanaka

M Taniguchi

Affiliations

Soon will be listed here.

Abstract

We have recently identified alpha-galactosylceramide (alpha-GalCer) as a specific ligand for an invariant Valpha14/Vbeta8.2 T cell receptor exclusively expressed on the majority of Valpha14 NKT cells, a novel subset of lymphocytes. Here, we report that alpha-GalCer selectively activates Valpha14 NKT cells resulting in prevention of tumor metastasis. The effector mechanisms of the ligand-activated Valpha14 NKT cells seem to be mediated by natural killer (NK)-like nonspecific cytotoxicity. Indeed, the cytotoxic index obtained by alpha-GalCer-activated Valpha14 NKT cells was reduced by the addition of cold target tumor cells or by treatment with concanamycin A, which inhibits activation and secretion of perforin, but not by mAbs against molecules involved in the NKT cell recognition and conventional cytotoxicity, such as CD1d, Vbeta8, NK1. 1, Ly49C, Fas, or Fas ligand. These results suggest that the ligand-activated Valpha14 NKT cells kill tumor cells directly through a CD1d/Valpha14 T cell receptor-independent, NK-like mechanism.

Citing Articles

Identification of Functional Immune Biomarkers in Breast Cancer Patients.

Derakhshandeh R, Zhu Y, Li J, Hester D, Younis R, Koka R Int J Mol Sci. 2024; 25(22).

PMID: 39596374 PMC: 11595306. DOI: 10.3390/ijms252212309.

Allogeneic chimeric antigen receptor cell therapies for cancer: progress made and remaining roadblocks.

Diorio C, Teachey D, Grupp S Nat Rev Clin Oncol. 2024; 22(1):10-27.

PMID: 39548270 DOI: 10.1038/s41571-024-00959-y.

Chemical synthesis and immunological evaluation of cancer vaccines based on ganglioside antigens and α-galactosylceramide.

Romano C, Jiang H, Tahvili S, Wei P, Keiding U, Clergeaud G RSC Med Chem. 2024; 15(8):2718-2728.

PMID: 39149099 PMC: 11324045. DOI: 10.1039/d4md00387j.

invariant Natural Killer T cell therapy as a novel therapeutic approach in hematological malignancies.

Boonchalermvichian C, Yan H, Gupta B, Rubin A, Baker J, Negrin R Front Transplant. 2024; 3:1353803.

PMID: 38993780 PMC: 11235242. DOI: 10.3389/frtra.2024.1353803.

Human CD4 iNKT cell adoptive immunotherapy induces anti-tumour responses against CD1d-negative EBV-driven B lymphoma.

Baiu D, Sharma A, Schehr J, Basu J, Smith K, Ohashi M Immunology. 2024; 172(4):627-640.

PMID: 38736328 PMC: 11223969. DOI: 10.1111/imm.13799.

References

Wakabayashi S, Okamoto S, Taniguchi M . Sandwich radioimmunoassay using single monoclonal antibody that detects minute amounts of melanoma antigens from various mammalian species. Gan. 1984; 75(5):427-32. View

Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, Motoki K . CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science. 1997; 278(5343):1626-9. DOI: 10.1126/science.278.5343.1626. View

Imai K, Kanno M, Kimoto H, Shigemoto K, Yamamoto S, Taniguchi M . Sequence and expression of transcripts of the T-cell antigen receptor alpha-chain gene in a functional, antigen-specific suppressor-T-cell hybridoma. Proc Natl Acad Sci U S A. 1986; 83(22):8708-12. PMC: 387000. DOI: 10.1073/pnas.83.22.8708. View

Budd R, Miescher G, Howe R, Lees R, Bron C, MacDonald H . Developmentally regulated expression of T cell receptor beta chain variable domains in immature thymocytes. J Exp Med. 1987; 166(2):577-82. PMC: 2189605. DOI: 10.1084/jem.166.2.577. View

Fowlkes B, Kruisbeek A, Ton-That H, Weston M, Coligan J, Schwartz R . A novel population of T-cell receptor alpha beta-bearing thymocytes which predominantly expresses a single V beta gene family. Nature. 1987; 329(6136):251-4. DOI: 10.1038/329251a0. View

Nores G, Dohi T, Taniguchi M, Hakomori S . Density-dependent recognition of cell surface GM3 by a certain anti-melanoma antibody, and GM3 lactone as a possible immunogen: requirements for tumor-associated antigen and immunogen. J Immunol. 1987; 139(9):3171-6. View

Ballas Z, Rasmussen W . NK1.1+ thymocytes. Adult murine CD4-, CD8- thymocytes contain an NK1.1+, CD3+, CD5hi, CD44hi, TCR-V beta 8+ subset. J Immunol. 1990; 145(4):1039-45. View

Sykes M . Unusual T cell populations in adult murine bone marrow. Prevalence of CD3+CD4-CD8- and alpha beta TCR+NK1.1+ cells. J Immunol. 1990; 145(10):3209-15. View

Levitsky H, Golumbek P, Pardoll D . The fate of CD4-8- T cell receptor-alpha beta+ thymocytes. J Immunol. 1991; 146(4):1113-7. View

10.

Takahama Y, Kosugi A, Singer A . Phenotype, ontogeny, and repertoire of CD4-CD8- T cell receptor alpha beta + thymocytes. Variable influence of self-antigens on T cell receptor V beta usage. J Immunol. 1991; 146(4):1134-41. View

11.

Takeda K, Dennert G . The development of autoimmunity in C57BL/6 lpr mice correlates with the disappearance of natural killer type 1-positive cells: evidence for their suppressive action on bone marrow stem cell proliferation, B cell immunoglobulin secretion, and.... J Exp Med. 1993; 177(1):155-64. PMC: 2190856. DOI: 10.1084/jem.177.1.155. View

12.

Bix M, Coles M, Raulet D . Positive selection of V beta 8+ CD4-8- thymocytes by class I molecules expressed by hematopoietic cells. J Exp Med. 1993; 178(3):901-8. PMC: 2191170. DOI: 10.1084/jem.178.3.901. View

13.

Bendelac A, Killeen N, Littman D, Schwartz R . A subset of CD4+ thymocytes selected by MHC class I molecules. Science. 1994; 263(5154):1774-8. DOI: 10.1126/science.7907820. View

14.

Yoshimoto T, Paul W . CD4pos, NK1.1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J Exp Med. 1994; 179(4):1285-95. PMC: 2191455. DOI: 10.1084/jem.179.4.1285. View

15.

Lantz O, Bendelac A . An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans. J Exp Med. 1994; 180(3):1097-106. PMC: 2191643. DOI: 10.1084/jem.180.3.1097. View

16.

Sumida T, Sakamoto A, Murata H, Makino Y, Takahashi H, Yoshida S . Selective reduction of T cells bearing invariant V alpha 24J alpha Q antigen receptor in patients with systemic sclerosis. J Exp Med. 1995; 182(4):1163-8. PMC: 2192293. DOI: 10.1084/jem.182.4.1163. View

17.

Yoshimoto T, Bendelac A, Hu-Li J, Paul W . Defective IgE production by SJL mice is linked to the absence of CD4+, NK1.1+ T cells that promptly produce interleukin 4. Proc Natl Acad Sci U S A. 1995; 92(25):11931-4. PMC: 40517. DOI: 10.1073/pnas.92.25.11931. View

18.

Yoshimoto T, Bendelac A, Watson C, Hu-Li J, Paul W . Role of NK1.1+ T cells in a TH2 response and in immunoglobulin E production. Science. 1995; 270(5243):1845-7. DOI: 10.1126/science.270.5243.1845. View

19.

Makino Y, Kanno R, Ito T, Higashino K, Taniguchi M . Predominant expression of invariant V alpha 14+ TCR alpha chain in NK1.1+ T cell populations. Int Immunol. 1995; 7(7):1157-61. DOI: 10.1093/intimm/7.7.1157. View

20.

Yu Y, George T, Dorfman J, Roland J, Kumar V, Bennett M . The role of Ly49A and 5E6(Ly49C) molecules in hybrid resistance mediated by murine natural killer cells against normal T cell blasts. Immunity. 1996; 4(1):67-76. DOI: 10.1016/s1074-7613(00)80299-x. View